Try
Bruker Corporation Common Stock
BRKRUnited States
110 filed reports · 947 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
110 reports · Dec 2008 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 224 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 48 | 224 | Dec 2008 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 47 | 8,670 | Mar 2011 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 15 | 10,729 | Dec 2011 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 497 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 4, 2026 | 8 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 366 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 27, 2026 | 1,838 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 437 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 222 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 7, 2025 | 222 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 3, 2025 | 900 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 7, 2024 | 281 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 9, 2024 | 226 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 10, 2024 | 234 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 29, 2024 | 787 | Open |
Financial data
947 concepts · 19,623 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial889 concepts · 17,095 facts · Dec 2008 to Jun 2026
- Cash and cash equivalents at carrying value85 · Dec 2008 to Jun 2026
- Cost of revenue (US GAAP)83 · Dec 2009 to Jun 2026
- Depreciation depletion and amortization83 · Dec 2009 to Jun 2026
- Gross profit (US GAAP)83 · Dec 2009 to Jun 2026
- Income tax expense benefit83 · Dec 2009 to Jun 2026
- Net income loss available to common stockholders basic83 · Dec 2009 to Jun 2026
- Operating expenses (US GAAP)83 · Dec 2009 to Jun 2026
- Operating income loss83 · Dec 2009 to Jun 2026
- Payments to acquire property plant and equipment83 · Dec 2009 to Jun 2026
- Profit loss83 · Dec 2009 to Jun 2026
- Research and development expense83 · Dec 2009 to Jun 2026
- Revenue83 · Dec 2009 to Jun 2026
- Selling general and administrative expense83 · Dec 2009 to Jun 2026
- Allocated share based compensation expense82 · Dec 2009 to Jun 2026
- Comprehensive income net of tax including portion attributable to noncontrolling interest82 · Dec 2009 to Jun 2026
- Increase decrease in other operating capital net82 · Mar 2010 to Jun 2026
- Stockholders equity including portion attributable to noncontrolling interest82 · Dec 2008 to Jun 2026
- Comprehensive income net of tax81 · Jun 2010 to Jun 2026
- Increase decrease in inventories81 · Dec 2009 to Jun 2026
- Proceeds from issuance of common stock81 · Dec 2009 to Dec 2025
- Amortization of intangible assets80 · Mar 2010 to Jun 2026
- Business combination acquisition related costs80 · Dec 2009 to Jun 2026
- Goodwill (US GAAP)80 · Dec 2009 to Jun 2026
- Net income loss80 · Mar 2010 to Jun 2026
Segment31 concepts · 1,528 facts · Dec 2009 to Jun 2026
- Revenue402 · Dec 2009 to Jun 2026
- Operating income loss249 · Dec 2009 to Jun 2026
- Total Assets142 · Dec 2010 to Jun 2026
- Depreciation depletion and amortization112 · Dec 2009 to Jun 2026
- Segment expenditure addition to long lived assets75 · Dec 2021 to Jun 2026
- Operating segments56 · Dec 2022 to Jun 2026
- Research and development expense56 · Dec 2022 to Jun 2026
- Selling general and administrative expense56 · Dec 2022 to Jun 2026
- Restructuring charges48 · Sep 2013 to Jun 2026
- Goodwill46 · Dec 2018 to Dec 2025
- Payments to acquire property plant and equipment45 · Dec 2010 to Dec 2022
- Goodwill foreign currency translation gain loss41 · Dec 2017 to Dec 2025
- BSI34 · Dec 2013 to Sep 2019
- Goodwill acquired during period31 · Dec 2017 to Dec 2025
- Number of operating segments28 · Sep 2013 to Sep 2019
- Asset impairment charges16 · Dec 2012 to Dec 2025
- Goodwill impairment loss13 · Dec 2012 to Jun 2026
- Restructuring and related cost incurred cost11 · Jun 2025 to Jun 2026
- Business exit costs18 · Mar 2014 to Sep 2016
- Goodwill purchase accounting adjustments8 · Dec 2023 to Dec 2025
- Other nonrecurring expense8 · Sep 2024 to Sep 2025
- Severance costs18 · Mar 2014 to Sep 2016
- Additions to noncurrent assets6 · Dec 2009 to Dec 2011
- Impairment of intangible assets finitelived6 · Dec 2012 to Dec 2015
Geography12 concepts · 457 facts · Dec 2009 to Jun 2026
- Revenue332 · Dec 2009 to Jun 2026
- Effective income tax rate reconciliation at federal statutory income tax rate34 · Dec 2017 to Mar 2026
- Japan34 · Dec 2019 to Dec 2025
- Property, Plant & Equipment, Net33 · Dec 2011 to Dec 2018
- Effective income tax rate reconciliation change in enacted tax rate10 · Dec 2017 to Dec 2024
- Income tax holiday aggregate dollar amount4 · Dec 2021 to Dec 2024
- Income tax holiday income tax benefits per share4 · Dec 2021 to Dec 2024
- Income tax paid foreign after refund received2 · Dec 2025
- Effective income tax rate reconciliation foreign income tax rate differential1 · Mar 2018
- Income tax paid federal after refund received1 · Dec 2025
- Income tax paid state and local after refund received1 · Dec 2025
- Korea1 · Dec 2015
Product4 concepts · 319 facts · Dec 2016 to Jun 2026
- Cost of revenue (US GAAP)159 · Dec 2016 to Jun 2026
- Revenue147 · Dec 2016 to Jun 2026
- Selling general and administrative expense12 · Dec 2016 to Dec 2025
- Cost of Revenue1 · Dec 2022
Guidance11 concepts · 224 facts · Mar 2009 to Aug 2026
- Revenue Growth Guidance68 · Mar 2009 to Aug 2026
- EPS (Diluted) Guidance46 · Oct 2010 to Aug 2026
- Revenue Guidance36 · Jan 2010 to Aug 2026
- Operating Margin Guidance30 · May 2015 to Feb 2020
- Effective Tax Rate Guidance8 · Feb 2016 to Aug 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))8 · Nov 2013 to May 2021
- Revenue Growth Guidance (Organic)8 · Nov 2013 to May 2021
- EPS (Diluted) Growth Guidance6 · Feb 2013 to May 2014
- EPS (Diluted) Growth Guidance (Adjusted (non-GAAP))6 · Nov 2018 to May 2021
- Operating Margin Growth Guidance (Adjusted (non-GAAP))6 · Nov 2018 to May 2021
- Free Cash Flow Guidance2 · Feb 2012
Segments
2,304 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments23 members · 1,456 facts
- Energy And Supercon Technologies321 · Dec 2009 to Jun 2026
- Scientific Instruments275 · Dec 2009 to Jun 2023
- Bsi Nano209 · Dec 2017 to Jun 2026
- Bsi Calid157 · Dec 2020 to Jun 2026
- Bsi Biospin137 · Dec 2020 to Jun 2026
- Energy and supercon technologies88 · Dec 2010 to Jun 2026
- Scientific instruments60 · Dec 2010 to Dec 2021
- Corporate57 · Dec 2017 to Jun 2026
- Bruker Bio Spin Group21 · Dec 2018 to Sep 2024
- Bruker Calid Group21 · Dec 2018 to Sep 2024
- Bruker Nano Group21 · Dec 2018 to Sep 2024
- Bsi nano14 · Dec 2018 to Dec 2025
- Biospin13 · Dec 2020 to Dec 2025
- Scientific Instruments Material Science12 · Dec 2017 to Dec 2019
- Unallocated Expenses12 · Dec 2022 to Dec 2025
- Bsibio spin calidnanoand corporate10 · Dec 2023 to Jun 2026
- BCA Restructuring Program7 · Jun 2024 to Dec 2025
- Bsi calid7 · Dec 2021 to Dec 2025
- Biospin5 · Dec 2021 to Dec 2025
- Adjustments And Reconciling Items4 · Mar 2025 to Jun 2026
- Bsi biospin2 · Dec 2024 to Sep 2025
- Bsi life science bsi material science corporate2 · Dec 2018 to Dec 2019
- Bbio Nano And Calid Segments1 · Sep 2024
Statement geographicalsrt:StatementGeographicalAxis18 members · 342 facts
- DE66 · Dec 2017 to Jun 2026
- US44 · Dec 2017 to Jun 2026
- Other Country43 · Dec 2017 to Jun 2026
- Rest Of Europe37 · Dec 2017 to Mar 2025
- CN28 · Dec 2020 to Jun 2026
- CH22 · Dec 2018 to Mar 2026
- Asia Pacific21 · Dec 2017 to Dec 2023
- Rest Of Asia Pacific19 · Mar 2021 to Mar 2025
- Asia Pacific Excluding China12 · Dec 2023 to Jun 2026
- Europe Excluding Germany12 · Dec 2023 to Jun 2026
- Germany And Switzerland8 · Dec 2018 to Dec 2024
- MY8 · Dec 2021 to Dec 2024
- FR7 · Dec 2019 to Dec 2025
- JP7 · Dec 2019 to Dec 2025
- TH4 · Dec 2020 to Dec 2023
- IT2 · Dec 2024 to Dec 2025
- Other Foreign Jurisdictions1 · Dec 2025
- Other State Jurisdictions1 · Dec 2025
Product or servicesrt:ProductOrServiceAxis5 members · 246 facts
- Product86 · Dec 2017 to Jun 2026
- Product And Service Other86 · Dec 2017 to Jun 2026
- Service56 · Dec 2017 to Dec 2023
- License9 · Dec 2017 to Dec 2025
- Shipping And Handling9 · Dec 2017 to Dec 2025
Statement geographicalus-gaap:StatementGeographicalAxis15 members · 115 facts
- DE16 · Dec 2009 to Dec 2018
- Other Country14 · Dec 2009 to Dec 2018
- US14 · Dec 2009 to Dec 2018
- Asia Pacific11 · Dec 2012 to Dec 2018
- Rest Of Europe11 · Dec 2012 to Dec 2018
- De8 · Dec 2011 to Dec 2018
- Us8 · Dec 2011 to Dec 2018
- Other country6 · Dec 2011 to Dec 2018
- Rest of europe6 · Dec 2013 to Dec 2018
- Segment Geographical Groups Of Countries Group One5 · Dec 2009 to Dec 2013
- Segment Geographical Groups Of Countries Group Two5 · Dec 2009 to Dec 2013
- Asia pacific5 · Dec 2013 to Dec 2018
- Germany And Switzerland3 · Dec 2017 to Dec 2018
- CH2 · Dec 2017 to Dec 2018
- KR1 · Dec 2015
Product or serviceus-gaap:ProductOrServiceAxis6 members · 73 facts
- Product22 · Dec 2016 to Dec 2018
- Product And Service Other22 · Dec 2016 to Dec 2018
- Service22 · Dec 2016 to Dec 2018
- License3 · Dec 2016 to Dec 2018
- Shipping And Handling3 · Dec 2016 to Dec 2018
- Product and service other1 · Dec 2022
Subsegments5 members · 72 facts
- Bruker Bio Spin Group24 · Dec 2015 to Sep 2020
- Bruker Calid Group16 · Mar 2018 to Sep 2020
- Bruker Nano Group16 · Mar 2018 to Sep 2020
- Bruker Chemical And Applied Markets Division14 · Dec 2012 to Jun 2015
- Bruker Biospin Preclinical Imaging2 · Sep 2015
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary61 claims from 12 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary175 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes14 claims from 1 reports · Dec 2025
- Risk factors83 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 4, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.